Create a Report

Please provide report title
Please provide location
Please provide details

Add more

Get alerts and updates for your case!

This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.

Please provide email or phone
Please provide email or phone

We do not show your email or contact info

Skip this step

Add photos or video

We recommend photos and videos to help explain your report

Add Photo/Video
Drop files here
Skip this step

Email or SMS copy of report

Enter below to get emailed a copy of your report, or sms a link to your report

Please provide email or phone
Please provide email or phone

Thank you for your report!

The report was
successfully sent!


Your report is queued - it may take up to 12 hours to process your report.


Email us at support@safelyhq.com if you have questions.

Recall notice

Potassium Chloride Injection recalled due to Potassium Chloride Overdose, USA

2 months ago source fda.gov

United States

Otsuka ICU Medical LLC is issuing a voluntary recall to the user level, for a MISLABELLED lot of POTASSIUM CHLORIDE Inj. 20 mEq, NDC 0990-7077-14. The OVERWRAP label of lot 1030613, Expiration Date: 09-30-2026 may incorrectly identify the product as POTASSIUM CHLORIDE Inj. 10 mEq with NDC 0990-7074-26. Otsuka ICU Medical LLC has identified this discrepancy due to a manufacturing issue. The dosage is correctly printed on the labeling affixed to the product bag which is not visible when the 10 mEq OVERWRAP is in place. This notification details the issue and the required steps for you to perform. The affected product lot was manufactured on 15 April 2025 and distributed in the United States between 23 May 2025 through 26 August 2025.

If the incorrect dosage on the 10 mEq overwrap is used instead of the correct 20mEq dosage printed on the product, an overdose of potassium chloride is possible. Overdose of potassium chloride can lead to hyperkalemia. Hazards of severe hyperkalemia after large intravenous overdoses causes neuromuscular dysfunction including muscle weakness, ascending paralysis, listlessness, vertigo, mental confusion, hypotension, cardiac dysrhythmias, or death from cardiac arrest. Premature infants, patients on chronic parenteral nutrition, patients who have a history of cardiac arrythmias, patients with chronic renal insufficiency, patients who have acute renal failure, patients on potassium-sparing diuretics—all are at risk for adverse and potentially fatal outcomes. Otsuka ICU Medical LLC has not received reports of adverse events associated with this issue to date.

The affected product lot (Located on the top left of the product bag or the case label is:

- NDC NUMBER: 0990-7077-14
- LIST NUMBER: 070770452
- PRODUCT: Potassium Chloride Injection 20 mEq
- LOT NUMBER: 1030613
- EXPIRATION DATE: September 30, 2026
- CONFIGURATION: 50 mL in Flexible Container

- NDC NUMBER: 0990-7074-26
- LIST NUMBER: 070740452
- PRODUCT: Potassium Chloride Injection 10 mEq
- LOT NUMBER: N/A
- EXPIRATION DATE: N/A
- CONFIGURATION: 100 mL in Flexible Container

DESCRIPTION OF CASES BEING RECALLED:

- NDC NUMBER: 0990-7077-14
- BARCODE NUMBER: (01)20309907077141
- LOT NUMBER: 1030613
- EXPIRATION DATE: September 30, 2026
- CONFIGURATION: 24 per case

The U.S. Food and Drug Administration (FDA) has been notified of this action.

Source: www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/otsuka-icu-medical-llc-issues-voluntary-nationwide-recall-20-meq-potassium-chloride-injection-due

#drugs #unitedstates

Recent Reports Near Me